Not so with the IdeaPad Slim 5i 16 Gen 9 -- you get an all-metal chassis. It's not the most rigid of aluminum enclosures -- there's some flex in the ... to the power button where it's often ...

Lenovo IdeaPad Flex 5 is a Windows 10 Home laptop with a 15.60-inch display that has a resolution of 1920x1080 pixels. It is powered by a Core i7 processor and it comes with 16GB of RAM. Graphics are ...

As of Feb. 5, get the Lenovo IdeaPad Flex 5i Chromebook for just $399 at Lenovo, down from its usual price of $400. That's ...

2. Lenovo is a top Chinese manufacturer of consumer electronics and entered the smartphone business in 2012. By offering power-packed devices at affordable prices it soon became a popular vendor ...

The Lenovo IdeaPad Pro 5i is powered by Intel's top Arrow Lake-H processor, the Core Ultra 9 285H, features a gorgeous ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co-develop oral treatments for the red blood cell disorder and other ...

16.2% on 5 mg after 28 weeks and 22% on 20 mg after 36 weeks. The figures come from an analysis that assessed the effect of amycretin if all people adhered to treatment. Novo made no mention of ...

Novo Nordisk closed up 4.5% Wednesday. Shares of obesity drug rival Eli Lilly, meanwhile, rose 1.4%. Speaking to CNBC Wednesday, CEO and President Lars Fruergaard Jørgensen said that the company ...

Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

Novo Nordisk announced phase 1b/2a clinical trial results for amycretin this morning. Patients taking the GLP-1 drug lost an average of 9.7% of their weight in 36 weeks. This is the best news Novo ...

Novo Nordisk shares rose sharply Friday after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial. Shares were 7 ...